Altimmune, Inc.

Altimmune, Inc. is a biopharmaceutical company engaged in the development of immunotherapeutics that address significant unmet medical needs. The company's primary focus is on advancing proprietary therapeutic candidates for the treatment of liver disease, obesity, and infectious diseases. Altimmune's innovative pipeline includes a range of product candidates that leverage unique non-invasive delivery methods, enhancing the therapeutic potential and patient compliance. As a player in the healthcare and life sciences sector, Altimmune, Inc. contributes to the development of cutting-edge treatments that have the potential to improve patient outcomes across various global health challenges. Headquartered in Gaithersburg, Maryland, Altimmune is positioned at the forefront of biopharmaceutical innovation, playing a crucial role in the expanding field of immunotherapy and biotechnological advancements. Its endeavors are significant in addressing critical health issues, potentially reshaping therapeutic approaches in the respective areas.